BARDA DRIVe ReDIRECT (Repurposing for Chem Threats)
Funds United States public health teams with BARDA DRIVe support for repurposing-focused solutions.
About
BARDA DRIVe ReDIRECT, short for Repurposing for Chem Threats, is BARDA's program for converting existing therapeutics into medical countermeasures against chemical threats. It sits under the same DRIVe platform and focuses on agents such as cyanide, opioids, nerve agents, chlorine, and sulfur mustard.
The program awards grants from $250k to $5m, with a median actual award of $750k, and it runs on…
Max award$5M
Realistic median$750K
Success rateOver 30%
Decision time—
No upcoming rounds verified. Cadence: Rolling.